Eugenol mitigates schizophrenia-like behavioral deficits, oxidative stress, apoptosis, neuroinflammation, and cholinergic dysfunction in ketamine-induced mice

DARU, Journal of Pharmaceutical Sciences · Published 2026-04-27 · DOI 10.1007/s40199-026-00603-3

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s40199-026-00603-3

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles